Ansbert K. Gadicke, M.D.
Managing Director, MPM Capital
Dr. Ansbert Gadicke is the founder of the MPM Group and in 1997 co-founded its asset management business. He led MPM’s effort to build its Advisory and Investment Banking business from 1992 to 1996 and started its Asset Management business in 1996. Prior to founding MPM, Dr. Gadicke was employed by The Boston Consulting Group. Dr. Gadicke received an M.D. from J.W. Goethe University in Frankfurt. He subsequently held research positions in biochemistry and molecular biology at the Whitehead Institute at MIT, Harvard University and the German Cancer Research Center.
He has published in leading scientific publications including Nature and Cell. Dr. Gadicke is a Director of Arriva, Helicos BioSciences, Elixir, Idenix Pharmaceuticals, Omrix Biopharmaceuticals, Nuvios, Pharmasset, PharmAthene and ViaCell. He previously served as a Director of BioMarin, Coelacanth, Kourion, MediGene and Transform. He is a member of Advisory Councils for Harvard Medical School and the Whitehead Institute at MIT. He serves as the Co-Chairman of the Alumni Association of the Whitehead Institute and serves on the Board of the National Venture Capital Association (NVCA).